World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
27906
World Ranking
2174
National Ranking
46

Sharon Walmsley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sharon Walmsley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 440 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sharon Walmsley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sharon Walmsley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sharon Walmsley is affiliated with the University Health Network in Canada and has a significant body of work in the field of medicine, with a specialized focus on infectious diseases, epidemiology, and virology. Their research contributions extend to emergency medicine and hepatology, demonstrating a broad engagement with clinical and public health challenges.

The scholar has made noteworthy contributions to topics related to HIV/AIDS research and interventions, HIV-related health complications and treatments, as well as HIV research and treatment. Their work also addresses SARS-CoV-2 and COVID-19 research, including clinical studies, and hepatitis C virus research. These areas reflect a comprehensive focus on viral infections and their impacts on human health.

Among recent publications, notable papers include the following:

  • Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022, published in 2022 by New England Journal of Medicine
  • Mpox in people with advanced HIV infection: a global case series, published in 2023 by The Lancet
  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection, published in 2020 by New England Journal of Medicine
  • Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial, published in 2021 by The Lancet Respiratory Medicine
  • Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, published in 2020 by Clinical Infectious Diseases

Frequent co-authors working alongside Sharon Walmsley include Curtis Cooper, Marina B. Klein, Darrell H. S. Tan, Mona Loutfy, and Mark Hull. This network indicates collaboration with researchers experienced across overlapping areas of infectious diseases and HIV research.

Publications by Walmsley often appear in journals with a strong focus on infectious diseases and HIV research, including AIDS, The Lancet HIV, HIV Medicine, Open Forum Infectious Diseases, and SSRN Electronic Journal.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

    Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner

  • Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

    Sharon L. Walmsley;Antonio Antela;Nathan Clumeck;Dan Duiculescu

  • Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

    Sharon Walmsley;Barry Bernstein;Martin King;José Arribas

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial

    Jean Michel Molina;Pedro Cahn;Beatriz Grinsztejn;Adriano Lazzarin

  • A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

    Daniel F. Martin;Juan Sierra-Madero;Sharon Walmsley;Richard A. Wolitz

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

    Charles B Hicks;Pedro Cahn;David A Cooper;Sharon L Walmsley

  • A Comparison of Two Regimens for the Treatment of Mycobacterium avium Complex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin

    Stephen D. Shafran;Joel Singer;Donald P. Zarowny;Peter Phillips

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.

    Johane P. Allard;Elaheh Aghdassi;Jenny Chau;Carolyn Tam

  • Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

    Joseph J. Eron;Bonaventura Clotet;Jacques Durant;Christine Katlama

  • Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987–1991

    B. Demers;A. E. Simor;H. Vellend;P. M. Schlievert

  • Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection

    J P Allard;E Aghdassi;J Chau;I Salit

  • Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-tropic HIV-1 Infection

    David A Cooper;Jayvant Heera;James Goodrich;Margaret Tawadrous

  • Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.

    Atul Humar;Daniel Gregson;Angela M. Caliendo;Allison McGeer

  • Psychosocial impact of the lipodystrophy syndrome in HIV infection.

    E Collins;C Wagner;S Walmsley

  • Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.

    Sharon Walmsley;Axel Baumgarten;Juan Berenguer;Franco Felizarta

  • Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

    François Coutlée;François Coutlée;Danielle Rouleau;Patrick Petignat;Georges Ghattas

  • Guidelines for the Treatment of Cytomegalovirus Diseases in Patients With AIDS in the Era of Potent Antiretroviral Therapy: Recommendations of an International Panel

    R J Whitley;M A Jacobson;D N Friedberg;G N Holland

Frequent Co-Authors

Marina B. Klein
Marina B. Klein McGill University
Rupert Kaul
Rupert Kaul University of Toronto
Robert S. Hogg
Robert S. Hogg Simon Fraser University
Tony Mazzulli
Tony Mazzulli University Health Network
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
François Coutlée
François Coutlée University of Montreal
Jonathan B. Angel
Jonathan B. Angel University of Ottawa
Colin Kovacs
Colin Kovacs University of Toronto
Alexander Wong
Alexander Wong University of Waterloo
Pedro Cahn
Pedro Cahn University of Buenos Aires

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees can open diverse career opportunities in healthcare and research. Many professionals start with an online ABSN programs for non nurses, designed specifically for individuals transitioning into nursing from other fields. These programs offer accelerated paths that combine theoretical knowledge with practical clinical experience.

Similarly, accelerated BSN programs for non nurses provide an efficient route to obtain a Bachelor of Science in Nursing, especially for those aiming to quickly enter the immunology sector in hospitals or laboratories. Admission criteria for these programs are often streamlined to attract diverse applicants.

Nursing pathways also include Licensed Practical Nurse credentials. Many applicants benefit from enrolling in easy admission LPN programs, which provide foundational skills crucial for patient care in immunology-related settings. These programs typically require less time, making them accessible for faster entry into nursing roles.

Advanced practice nurses can further enhance their expertise through the easiest NP program options. These programs prepare nurses for specialized roles, such as immunology-focused nurse practitioners, who play vital roles in diagnosis, treatment, and patient education.

Best Scientists Citing Sharon Walmsley

Trending Scientists

Recently Published Articles